471 related articles for article (PubMed ID: 31095066)
1. VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.
Aronow ME; Wiley HE; Gaudric A; Krivosic V; Gorin MB; Shields CL; Shields JA; Jonasch EW; Singh AD; Chew EY
Retina; 2019 Dec; 39(12):2243-2253. PubMed ID: 31095066
[TBL] [Abstract][Full Text] [Related]
2. Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease.
Daniels AB; Chang EY; Chew EY; Gombos DS; Gorin MB; Shields CL; Wiley HE
Ophthalmology; 2024 May; 131(5):622-633. PubMed ID: 38092079
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastoma.
Fu XM; Zhao SL; Gui JC; Jiang YQ; Shen MN; Su DL; Gu BJ; Wang XQ; Ren QJ; Yin XD; Huang WB; Chen XG
Genet Mol Res; 2015 May; 14(2):4513-20. PubMed ID: 25966224
[TBL] [Abstract][Full Text] [Related]
4. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
5. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
[TBL] [Abstract][Full Text] [Related]
6. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
Dollfus H; Massin P; Taupin P; Nemeth C; Amara S; Giraud S; Béroud C; Dureau P; Gaudric A; Landais P; Richard S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3067-74. PubMed ID: 12202531
[TBL] [Abstract][Full Text] [Related]
7. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
8. Von hippel-lindau disease: a genetic and clinical review.
Haddad NM; Cavallerano JD; Silva PS
Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
[TBL] [Abstract][Full Text] [Related]
9. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease.
Wu X; Chen L; Zhang Y; Xie H; Xue M; Wang Y; Huang H
BMC Med Genet; 2018 Nov; 19(1):204. PubMed ID: 30477447
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
13. von Hippel-Lindau disease: a clinical and scientific review.
Maher ER; Neumann HP; Richard S
Eur J Hum Genet; 2011 Jun; 19(6):617-23. PubMed ID: 21386872
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?
Azimi F; Aghajani A; Khakpour G; Chaibakhsh S
Mol Genet Genomics; 2022 Nov; 297(6):1615-1626. PubMed ID: 36006455
[TBL] [Abstract][Full Text] [Related]
15. DNA-based diagnosis of the von Hippel-Lindau syndrome.
Patel RJ; Appukuttan B; Ott S; Wang X; Stout JT
Am J Ophthalmol; 2000 Feb; 129(2):258-60. PubMed ID: 10682986
[TBL] [Abstract][Full Text] [Related]
16. [Genetics and angiogenesis: the example of von Hippel-Lindau disease].
Richard S; Ladroue C; Gad S; Giraud S; Gardie B;
Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002
[TBL] [Abstract][Full Text] [Related]
17. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
[TBL] [Abstract][Full Text] [Related]
18. Familial and genetic researches on three Chinese families with von Hippel-Lindau disease.
Mao XC; Su ZP; Yu WQ; Zheng WM; Zeng YJ
Neurol Res; 2009 Sep; 31(7):743-7. PubMed ID: 19133167
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
Webster AR; Maher ER; Moore AT
Arch Ophthalmol; 1999 Mar; 117(3):371-8. PubMed ID: 10088816
[TBL] [Abstract][Full Text] [Related]
20. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
